ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $2,623,000 | -3.7% | 44,045 | +10.3% | 0.01% | -15.4% |
Q2 2021 | $2,723,000 | +92.2% | 39,923 | +95.5% | 0.01% | +85.7% |
Q1 2021 | $1,417,000 | +28.4% | 20,418 | +42.1% | 0.01% | +40.0% |
Q4 2020 | $1,104,000 | +10.1% | 14,365 | +7.2% | 0.01% | -16.7% |
Q3 2020 | $1,003,000 | +32.1% | 13,406 | +11.2% | 0.01% | +50.0% |
Q2 2020 | $759,000 | – | 12,053 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 4,190,000 | $321,918,000 | 5.54% |
Prosight Management, LP | 145,700 | $11,194,000 | 5.17% |
Integral Health Asset Management, LLC | 200,000 | $15,366,000 | 4.57% |
Copernicus Capital Management, LLC | 3,740 | $287,000 | 4.47% |
GREAT POINT PARTNERS LLC | 345,120 | $26,516,000 | 4.31% |
Asymmetry Capital Management, L.P. | 101,245 | $7,779,000 | 3.55% |
First Light Asset Management, LLC | 321,967 | $24,737,000 | 1.83% |
DAFNA Capital Management LLC | 76,815 | $5,902,000 | 1.76% |
SECTORAL ASSET MANAGEMENT INC | 320,059 | $24,590,000 | 1.73% |
Nicholas Investment Partners, LP | 276,633 | $21,254,000 | 1.64% |